ESC 365 - The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial

ESC Premium Access

The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial

Session: Late-Breaking Science Posters PCI

Topic: Thrombosis and coagulation

Speaker: Professor J. Mcevoy (Galway, IE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor John William Mcevoy

National University of Ireland, Galway (Ireland)

11 presentations

12 followers

4 more presentations in this session

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Speaker: Professor G. Mancini (Vancouver, CA)

Stroke after coronary revascularization: an individual patient data pooled analysis of 11 randomised trials comparing percutaneous coronary intervention with coronary artery bypass grafting

Speaker: Doctor S. Head (Rotterdam, NL)

The EROSION study (Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion): A 1-Year Follow Up Study

Speaker: Professor I. Jang (Boston, US)

A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: final results of the Elderly-ACS

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)

Access the full session

Late-Breaking Science Posters PCI

Speakers: Professor J. Mcevoy, Professor G. Mancini, Doctor S. Head, Professor I. Jang, Professor S. De Servi

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources